|
| Status |
Public on Aug 10, 2016 |
| Title |
Imipramine Blue: A potent therapeutic regimen that suppresses breast cancer growth and metastasis |
| Organism |
Homo sapiens |
| Experiment type |
Expression profiling by array
|
| Summary |
Imipramine Blue a novel inhibitor that we recently synthesiszed suppressed breast cancer growth and progression by silencing FOXM1 and its associated signaling.
|
| |
|
| Overall design |
Breast cancer cell-line MDA-MB-231 treated with vehicle (DMSO) and IB, with 2 biological replciates each.
|
| |
|
| Contributor(s) |
Rajamanickam S, Rao MK |
| Citation(s) |
26927663 |
| |
| Submission date |
Aug 25, 2015 |
| Last update date |
Jun 27, 2018 |
| Contact name |
Yidong Chen |
| E-mail(s) |
cheny8@uthscsa.edu
|
| Phone |
2105629163
|
| Organization name |
UT Health Science Center at San Antonio
|
| Department |
Population Health Sciences
|
| Street address |
8403 Floyd Curl Drive, MSC 7784
|
| City |
San Antonio |
| State/province |
Texas |
| ZIP/Postal code |
78229 |
| Country |
USA |
| |
|
| Platforms (1) |
| GPL10904 |
Illumina HumanHT-12 V4.0 expression beadchip (gene symbol) |
|
| Samples (4)
|
|
| Relations |
| BioProject |
PRJNA293880 |
Less...
More...